[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-370249-105":59,"doc-detail-370249-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","user-and-developer-views-on-using-ai-technologies-to-facilitate-the-early-detection-of-skin-cancers-in-primary-care-settings-qualitative-semistructured-interview-study","User and Developer Views on Using AI Technologies to Facilitate the Early Detection of Skin Cancers in Primary Care Settings - Qualitative Semistructured Interview Study","","Skin cancers, including melanoma and keratinocyte cancers, are increasingly common worldwide, and earlier detection improves patient outcomes. Many AI diagnostic technologies exist, yet many lack clinical evidence and appropriate regulatory approvals, and few qualitative studies address stakeholder views on implementation. This qualitative semistructured interview study explored perspectives of patients, public members, primary care practitioners, dermatologists, and AI researchers via Zoom interviews.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/user-and-developer-views-on-using-ai-technologies-to-facilitate-the-early-detection-of-skin-cancers-in-primary-care-settings-qualitative-semistructured-interview-study/370249/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/user-and-developer-views-on-using-ai-technologies-to-facilitate-the-early-detection-of-skin-cancers-in-primary-care-settings-qualitative-semistructured-interview-study/370249.png","ImageObject",300,407,{"name":92,"@type":93},"Ivy","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-05","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the study objective regarding AI in skin cancer detection?","Question",{"text":112,"@type":113},"The study aimed to understand stakeholder views on using AI technologies to facilitate early diagnosis of skin cancer in primary care settings.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were participants selected and interviews conducted?",{"text":117,"@type":113},"Participants were purposively sampled by age, sex, and geographical location, and interviews were conducted via Zoom between September 2022 and May 2023.",{"name":119,"@type":110,"acceptedAnswer":120},"What concerns did participants raise about implementing AI technologies?",{"text":121,"@type":113},"Participants were concerned about the quality of data used to develop and test AI systems, potential accuracy impacts across demographics, risk of missing skin cancers, and ease of use without increasing workload.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},370249,1791080340,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":56,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},549758252649,"https://ap-avatar.wpscdn.com/avatar/8000253669c5317157?_k=1778319167496531819","JMIR CANCER Jones et al  \nOriginal Paper  \nUser and Developer Views on Using AI Technologies to Facilitate the Early Detection of Skin Cancers in Primary Care Settings: Qualitative Semistructured Interview Study  \n\n| Owain Tudor Jones 1, BSc, BMBS, MPhil; Natalia Calanzani2, BSc, MSc, PhD; Suzanne E Scott3, BSc, MSc, PhD; Rubeta N Matin4, PhD; Jon Emery3,5, DPhil; Fiona M Walter3,5, MA, MD |\n| --- |\n| 1Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom 2Institute of Applied Health Sciences, University of Aberdeen, Aberdeen, United Kingdom\u003Cbr>3Wolfson Institute of Population Health, Queen Mary University of London, London, United Kingdom 4Department of Dermatology, Churchill Hospital, Oxford, United Kingdom\u003Cbr>5Centre for Cancer Research, and Department of General Practice and Primary Care, University of Melbourne, Melbourne, Australia\u003Cbr>Corresponding Author:\u003Cbr>Owain Tudor Jones, BSc, BMBS, MPhil Department of Public Health and Primary Care\u003Cbr>University of Cambridge East Forvie Building Robinson Way Cambridge, CB2 0SZ United Kingdom Phone: 44 7737204055\u003Cbr>Email: [otj24@medschl.cam.ac.uk](otj24@medschl.cam.ac.uk)\u003Cbr>Abstract |\n\nBackground: Skin cancers, including melanoma and keratinocyte cancers, are among the most common cancers worldwide, and their incidence is rising in most populations. Earlier detection of skin cancer leads to better outcomes for patients. Artificial intelligence (AI) technologies have been applied to skin cancer diagnosis, but many technologies lack clinical evidence and/orthe appropriate regulatory approvals. There are few qualitative studies examining the views of relevant stakeholders or evidence about the implementation and positioning of AI technologies in the skin cancer diagnostic pathway.  \nObjective: This study aimed to understand the views of several stakeholder groups on the use of AI technologies to facilitate the early diagnosis of skin cancer, including patients, members of the public, general practitioners, primary care nurse practitioners, dermatologists, and AI researchers.  \nMethods: This was a qualitative, semistructured interview study with 29 stakeholders. Participants were purposively sampled based on age, sex, and geographical location. We conducted the interviews via Zoom between September 2022 and May 2023. Transcribed recordings were analyzed using thematic framework analysis. The framework for the Nonadoption, Abandonment, and Challenges to Scale-Up, Spread, and Sustainability was used to guide the analysis to help understand the complexity of implementing diagnostic technologies in clinical settings.  \nResults: Major themes were “the position of AI in the skin cancer diagnostic pathway” and “the aim of the AI technology”; cross-cutting themes included trust, usability and acceptability, generalizability, evaluation and regulation, implementation, and long-term use. There was no clear consensus on where AI should be placed along the skin cancer diagnostic pathway, but most participants saw the technology in the hands of either patients or primary care practitioners. Participants were concerned about the quality of the data used to develop and test AI technologies and the impact this could have on their accuracy in clinical use with patients from a range of demographics and the risk of missing skin cancers. Ease of use and not increasing the workload of already strained health care services were important considerations for participants. Health care professionals and AI researchers reported a lack of established methods of evaluating and regulating AI technologies.  \nConclusions: This study is one of the first to examine the views of a wide range of stakeholders on the use of AI technologies to facilitate early diagnosis of skin cancer. The optimal approach and position in the diagnostic pathway for these technologies  \n[https://cancer.jmir.org/2025/1/e60653](https://cancer.jmir.org/2025/1/e60653)  \nXSL• FO  \nRenderX  \nJMIR Cancer","cbCaijpZO5eLDTqu","https://ap.wps.com/l/cbCaijpZO5eLDTqu","pdf",993618,"English","# Abstract\n# Introduction\n## Background\n# Methods\n## Participants and recruitment\n## Data collection and analysis\n# Results\n## Major themes and cross-cutting themes\n# Conclusions","[{\"question\":\"What was the study objective regarding AI in skin cancer detection?\",\"answer\":\"The study aimed to understand stakeholder views on using AI technologies to facilitate early diagnosis of skin cancer in primary care settings.\"},{\"question\":\"How were participants selected and interviews conducted?\",\"answer\":\"Participants were purposively sampled by age, sex, and geographical location, and interviews were conducted via Zoom between September 2022 and May 2023.\"},{\"question\":\"What concerns did participants raise about implementing AI technologies?\",\"answer\":\"Participants were concerned about the quality of data used to develop and test AI systems, potential accuracy impacts across demographics, risk of missing skin cancers, and ease of use without increasing workload.\"}]","User and Developer Views on Using AI Technologies to Facilitate the Early Detection of Skin Cancers in Primary Care Settings - Qualitative Semistructured Interview Study | PDF",1790187606,48,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fd5ab648b8a269bf9140adc8b40f7c21.webp",983,1390,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ee05f982e6aa738bff4168f33b55720b.webp",982,1388,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/de695e58a52ee1a6e5d2a8a694cacf2c.webp",981,1387,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/314381bae491a1c1f14e9c43d928997d.webp",980,1385]